Processing

Please wait...

Settings

Settings

1. WO2016193244 - AMINOESTER DERIVATIVES

Publication Number WO/2016/193244
Publication Date 08.12.2016
International Application No. PCT/EP2016/062229
International Filing Date 31.05.2016
IPC
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
409
Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
14
containing three or more hetero rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11
Drugs for disorders of the respiratory system
C07D 409/14 (2006.01)
A61K 31/44 (2006.01)
A61P 11/00 (2006.01)
CPC
A61K 31/4436
A61K 31/4439
A61K 31/444
A61K 31/4535
A61K 31/4545
A61K 31/46
Applicants
  • CHIESI FARMACEUTICI S.P.A. [IT/IT]; Via Palermo, 26/A 43100 Parma, IT
Inventors
  • AMARI, Gabriele; IT
  • ARMANI, Elisabetta; IT
  • BLACKABY, Wesley; IT
  • VAN DE PÖEL, Hervé; IT
  • BAKER-GLENN, Charles; IT
  • TRIVEDI, Naimisha; IT
Agents
  • MINOJA, Fabrizio; IT
Priority Data
15170041.601.06.2015EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) AMINOESTER DERIVATIVES
(FR) DÉRIVÉS D'AMINOESTER
Abstract
(EN)
The invention relates to novel compounds which are both phosphodiesterase 4 (PDE4) enzymeinhibitorsand muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
(FR)
L'invention concerne de nouveaux composés qui sont à la fois des inhibiteurs de l'enzyme phosphodiestérase 4 (PDE4) et des antagonistes des récepteurs muscariniques M3, des procédés de préparation de tels composés, des compositions les contenant et l'utilisation thérapeutique de ceux-ci.
Latest bibliographic data on file with the International Bureau